Pharmaceutical

Expert.ai Wins Duck Creek 2024 Hatch-a-Thon

Expert.ai showcased its innovative AI-powered claims solution at Formation '24 conference in Dallas, where Duck Creek Advisory Board and attendees…

4 months ago

ACTO ACQUIRES 4TH DOWN SOLUTIONS, BRINGING TOGETHER TWO INDUSTRY LEADERS

Strategic Acquisition Adds to ACTO's Organic Customer Growth in Top 50 Pharma KISSIMMEE, Fla., June 11, 2024 /PRNewswire/ - Today…

4 months ago

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

PathAI remains an independent company, focused on developing innovative AI and digital pathology solutions SECAUCUS, N.J. and BOSTON, June 11,…

4 months ago

AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption

Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer NEW ORLEANS, June 11, 2024 /PRNewswire/ -- AxoSim, a life…

4 months ago

NTT DATA Acquires Majority Stake in ProvenTech

Strengthening its Pharma/Life Science Expertise and Software Portfolio in India BIELEFELD, Germany and HYDERABAD, India, June 11, 2024 /PRNewswire/ -- NTT…

4 months ago

Benchling Builds Digital Data Foundation Powering Sanofi AI-Driven R&D

Over 30 global teams and 1,500 scientists at Sanofi use Benchling for R&D data capture and analysis SAN FRANCISCO, June…

4 months ago

Uniphar Logistics Backing SkyCell on Their Journey Towards Net-zero.

RALEIGH, NC / ACCESSWIRE / June 11, 2024 / Sky Cell AG, founded in Switzerland, continues paving the way for…

4 months ago

Optimi Health Completes First International Shipment of MDMA to Israel and Secures CBSA Exporters Authorization ID

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…

4 months ago

NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)

ZURICH, SWITZERLAND / ACCESSWIRE / June 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

4 months ago

Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More SHELTON, CT…

4 months ago